Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
P.CarpenterJ
Coverage for GLP-1s remains a key challenge for employers to navigate, as there is significant demand for the drugs that often come at a high cost
According to a large, real-world database study, the use of glucagon-like peptide 1 receptor agonists (GLP1RA) was associated with improved inflammatory bowel disease (IBD)-related outcomes among patients with ulcerative colitis (UC) and Crohns disease (CD)
This retrospective observational study links GLP-1 receptor agonist therapy with nutritional deficiencies and muscle loss in adults with type 2 diabetes
US$ 29.37
US$ 22.90
US$ 29.60
US$ 21.88
